Nilgün Özçakar, Aslıhan Çiflik Bolluk, Volkan Bolluk

Bireylerin Yaşa Bağlı Makula Dejenerasyonu Hakkında Bilgi Düzeyi

Giriş: Yaşa Bağlı Maküla Dejenerasyonu “YBMD”, gelişmiş ülkelerde 65 yaş ve üzeri kişilerde santral görme kaybının en sık nedenidir. Bireylerin risk faktörlerini bilmesi, yaşam tarzını düzenlemesi önem taşımaktadır. Amaç: Bireylerin YBMD hakkındaki bilgi düzeylerini ölçmek ve farkındalığını artırmak. Yöntem: Çalışmamız kesitsel tanımlayıcı bir araştırma olarak planlanmıştır. Aile Hekimliği polikliniğine Aralık 2015-Mart 2016 tarihlerinde herhangi bir nedenle başvuran 18 yaş ve üstü bireylere sosyo-demografik veriler ve sarı nokta hastalığı hakkındaki bilgi düzeyinin sorgulandığı soruların bulunduğu anket formu yüz yüze görüşme yöntemiyle uygulanmıştır. İstatistiksel analizlerde SPSS 15.0 programı kullanılmış, p

Level of Individuals’ Knowledge About Age-Related Macular Degeneration

Background: Age-Related Macular Degeneration "AMD" is the most common cause of central vision loss in developedcountries over 65 years of age. It is of importance to know the risk factors and regulate life style. Aim: To evaluate the levelof individuals ‘knowledge and raise their awareness. Method: The present study is planned as a cross-sectional descriptivestudy. A questionnaire form composed of questions about the socio-demographic data and the level of knowledge aboutAMD was applied to the patients18 years and over who were admitted to Family Medicine outpatient clinic due to anyreasons between December 2015 and March 2016 with face-to-face interviews. SPSS 15.0 program was used for statisticalanalysis, a p level of

PDF

___

1. Haab O. Erkrankungen der Maculalutea. Centralblat Augenheilkd 1885;9:384-91.
2. Atmaca LS. Senil dissiform makula dejeneresansı. Turaçlı ME, editör. Maküla Hastalıkları, retina arter ven tıkanıklıkları, Ankara: IV. Ulusal Oftalmoloji Kursu; 1984. S. 23-35.
3. Gass JMD. Pathogenesis of disciform detachment of the neuro epithelium: (1. General conseptsand classification. III. Senile disciform macular degeneration.) Am J Opthalmol. 1967;63:573-85.
4. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham Eye Study Monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabeticretinopathy, maculardegeneration, andvisualacuity in a general population of 2631 adults, 1973-1975. SurvOphthalmol. 1980;24(Suppl.):335-610.
5. Klein R, Klein BE, Jensen SC, Meuer SM. Thefive-year incidence and progression of agerelated maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104(1):7-21.
6. Rahmani B, Tielsch JM, Katz J, Gottsch J, Quigley H, Javitt J, et al. Thecause-specific prevalence of visual impairment in an urban population .The Baltimore Eye Survey. Ophthalmology 1996;103(11):1721-6.
7. Gass JDM. Stereoscopic atlas of maculardiseases; diagnosis and treatment, 4th edn. St Louis: CV Mosby; 1997.p.70-2.
8. Lotery A, Xu X, Zlatava G, Loftus J. Burden of illness, visual impairment and Health resource utilisation of patients with neovascularagerelated macular degeneration: results from the UK cohort of a five-countrycrosssectionalstudy. Br J Ophthalmol. 2007;91(10):1303-7.
9. Liu TY, Shah AR, Del Priore LV. Progression of lesion size in untreated eyes with exudative age-related macular degeneration a metaanalysis using Lineweaver–Burk plots. JAMA Ophthalmol. 2013;131(3):335-40.
10. Odwyer PA. ve Akova YA. Temel göz hastalıkları. 3.Baskı. Ankara:Güneş Tıp Kitabevleri;2015.p.677-685.
11. KanskiJJ. and Bowling B. Klinik OftalmolojiSistemik Yaklaşım. Akkova YA, çeviri editörü.7. Baskı. Ankara:Güneş Tıp Kitabevleri; 2015.p.611-617.
12. Candemir B. Yaş tip yaşa bağlı maküla dejenerasyonunda görme keskinliğinin, Floresein Anjiografi ve Optik Koherens Tomografi bulguları ile ilişkisi.T.C.S.B. Göztepe Eğitim ve Araştırma Hastanesi Göz Hastalıkları Uzmanlık Tezi. İstanbul: 2009:8- 12.
13. Barthelmes D, Campain A, Nguyen P, Arnold JJ, McAllister IL, Simpson JM, et al. Blindness! Project Investigators. Effects of switching from ranibizumab to aflibercept in eyes with exudativeage-related macular degeneration. Br J Ophthalmol.2016;100:1640- 5.
14. Burgmüller M, Cakmak N, Weingessel B, Vécsei C, Vécsei-MarlovitsetPV.Patient knowledge concerning age-related macular degeneration: an AMD questionnaire. Wien Klin Wochenschr, 2017;129:345-50.
15. Sanjay S, Chin YC, Teo HT, Ong SX, Toh SHF, KhongMH. A follow-upsurvey on the knowledge of age-related macular degeneration and its risk factors among Singapore residents after 5 years of nation-wide awareness campaigns. Ophthalmic Epidemiology 2014;21(4):230-6.
16. Stevens R,Bartlett H, Walsh R, CookeetR. Age-related macular degeneration patients’ awareness of nutritional factors. British Journal of Visual Impairment, 2014;32(2):77-93.
17. Cimarolli VR, Laban-Baker A, Hamilton WS, Stuenet C. Awareness, knowledge, and concern about age-related macular degeneration. Educational Gerontology 2012;38(8):530-8.
18. Kornbluth, JG,Wu G, RosenthalJ, YoonY, MossyA, Chowanadi saiM, WongM, EstreicherM.B. Using a Questionnaire to Assess Knowledge of Age Related Macular Degeneration in a Clinical Practice Setting. Investigative Ophthalmology & Visual Science 2003;44(13):1808-1808.
19. Zhang CX, Zhang GM, Ma N, Xia S, Yang JY, Chen YX. Awareness of Age-related Macular Degeneration and Its Risk Factors among Beijing Residents in China. Chin Med J 2017;130:155-9.
20. Bressler NM. Early detection and treatment of neovascular age-related macular degeneration. J Am Board FamPract 2002;15(2):142-52.
21. http://www.woncaeurope.org/sites/default/files/ documents/WONCAdefinitionTurkishversion.p df Accessed:21.08.2015